Senior insider sale
Chief Medical Officer at MADRIGAL PHARMACEUTICALS, INC. — senior position signals high conviction
$442.0K
844.00 shares
What this filing means
SOERGEL DAVID plans to sell 844.00 shares of MADRIGAL PHARMACEUTICALS, INC. valued at approximately $442.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 5/18/2026ACC: 0001628280-26-036075
Officer· Chief Medical Officer
Since Mar 2026
844.00
Shares to sell
$442.0K
Approx. market value
844.00
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Unit Grant
Vesting of Restricted Stock Units
5/15/2026
844.00Total acquired844.00
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
5/15/2026 | Restricted Stock Unit Grant Vesting of Restricted Stock Units | 844.00 | — |
| Total | 844.00 | ||
Planned & Completed Dispositions1
Nasdaq Stock MarketPlanned
Units to sell
844.00
Market value
$442.0K
5/18/2026
Total
Units
844.00
Value
$442.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
5/18/2026 | 844.00 | $442.0K | Nasdaq Stock Market | Planned |
| Total | 844.00 | $442.0K | ||